Stock screener
All disclosures →
EDGAR →
JNJ
Conviction 80HealthcareScan · Fri, Sep 4, 2026Shooting star
JNJ$275.19-1.16%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
2
2
Vol MA14 6.48M
Jun 8Jun 25Jul 15Jul 31Aug 19Sep 4
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 8Jun 25Jul 15Jul 31Aug 19Sep 4
Price275.19
Change-1.16%
Gap-1.20%
Rel volume0.60×
Avg volume6.26M
Avg $ vol1.68B
SMA 20268.26
SMA 50261.77
SMA 200235.82
Price vs 50+5.13%
Price vs 200+16.69%
MA stackbullish
50/200 cross—
Supertrendup · 260.36
RSI (14)61
MACD hist0.37
MACD crossbull · 2d
Stoch %K / %D66 / 76
ADX (14)24
+DI / −DI32 / 15
RSI divergence—
MACD divergence—
ATR %+2.01%
ADR %1.77%
52w high278.43
52w low174.16
From 52w high-1.16%
Above 52w low+58.01%
New 52w highNo
SqueezeOff
Bollinger width8.25%
%B0.81
Donchian pos77.22%
Donchian high281.07
Donchian low255.26
AVWAP (52w high)276.53
vs AVWAP high-0.48%
AVWAP (52w low)225.77
vs AVWAP low+21.89%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d0.60×
Avg vol (14d)6.45M
Avg vol (20d)6.26M
Avg $ vol (20d)1.68B
Market cap663.18B
RS 3m (vs SPY)+19.90%
RS 6m (vs SPY)+2.71%
RS line new highNo
Trend template8/8
Technical rank77.3
1 week+2.67%
1 month+7.09%
3 months+18.22%
6 months+14.47%
1 year+53.94%
YTD+32.72%
P/E24.74
P/B7.80
P/S7.04
P/FCF33.67
EPS11.03
Div yield—
ROE31.54%
ROA13.33%
Debt/Eq0.46
Current1.09
EV/EBITDA23.45
Gross margin67.88%
Net margin28.46%
Rev growth6.05%
EPS growth90.56%
Price target285.82
Target upside3.86%
Analyst ratingBuy
Institutional85.66%
Ent. value682.1B
Revenue25.31B
Net income5.53B
Gross profit17.26B
Free cash flow19.7B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out2.41B
Employees140.8K
ListedMon, Sep 25, 1944
Free float2.41B
Float %100.0%
Short interest21.59M
Days to cover3.3d
Short volume50.1%
Squeeze score25 / 100
Next earningsTue, Oct 13, 2026 · pre-mkt (39d)
EPS forecast$2.95 · 6 est
Last EPS vs est$2.90 vs $2.84
Last surprise+2.1% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank77.3 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Sun, Jun 28, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upAug 25 – Aug 315 scans
- Breaking out nowSep 11 scan
- Broke outSep 2 – Sep 32 scans
Congress activity
Disclosed STOCK Act trades in JNJ · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Richard Dean Dr McCormick house · R · GA · traded 2026-07-30 | Sell | $1K–$15K | 2026-07-30 | 2026-08-14 | |
 Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $1K–$15K | 2026-03-30 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $15K–$50K | 2026-03-27 | 2026-07-21 | |
Thomas H. Kean house · R · NJ · traded 2026-06-02 | Sell | $1K–$15K | 2026-06-02 | 2026-07-15 | |
Thomas H. Kean house · R · NJ · traded 2026-06-29 | Sell | $1K–$15K | 2026-06-29 | 2026-07-15 | |
Lloyd Doggett house · D · TX · traded 2026-06-09 | Buy | $1K–$15K | 2026-06-09 | 2026-07-06 | |
 John Boozman senate · R · AR · traded 2026-03-19 | Sell | $1K–$15K | 2026-03-19 | 2026-04-14 | |
Lloyd Doggett house · TX · traded 2025-12-09 | Buy | $1K–$15K | 2025-12-09 | 2026-01-02 |
Insider activity
SEC Form 4 transactions in JNJ · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Taubert Jennifer L EVP, WWC. Innovative Medicine · Common Stock · 2026-08-17 | Sell | 15K | $4.0M | 2026-08-17 | 2026-08-18 |
Taubert Jennifer L EVP, WWC. Innovative Medicine · Common Stock · 2026-08-17 | Exercise | 15K | $1.7M | 2026-08-17 | 2026-08-18 |
Taubert Jennifer L EVP, WWC. Innovative Medicine · Employee Stock Options (Right to Buy) · 2026-08-17 | Exercise | 15K | — | 2026-08-17 | 2026-08-18 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Sell | 102.31K | $27M | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Employee Stock Options (Right to Buy) · 2026-08-13 | Exercise | 123.29K | — | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Exercise | 123.29K | $14M | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Sell | 20.98K | $5.5M | 2026-08-13 | 2026-08-14 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Exercise | 9.34K | $1.2M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 9.34K | $2.4M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 6.57K | $1.7M | 2026-08-06 | 2026-08-07 |
SEC filings
EDGAR filings in JNJ · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.